Interestingly, regulatory T cells (Tregs) inhibit tumor-responsive activated CD4+ T cells by inhibiting cDC2, and Tregs also inhibit mature DCs and prevent their migration to draining lymph nodes (40, 41). This evidence concerns the gene CD4 and neoplasm.